# Post-Market Study of Low-flow ECCO2R Using PrismaLung+

> **NCT04617093** · NA · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 63 (actual)

## Conditions studied

- Mild to Moderate Acute Respiratory Distress Syndrome

## Interventions

- **DEVICE:** PrismaLung+

## Key facts

- **NCT ID:** NCT04617093
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-30
- **Primary completion:** 2023-12-05
- **Final completion:** 2024-01-10
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04617093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04617093, "Post-Market Study of Low-flow ECCO2R Using PrismaLung+". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04617093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*